Evidence-Based Complementary and Alternative Medicine

Research Article

Effect of Fractioning on Antibacterial Activity of Enantia chlorantha Oliver (Annonaceae) Methanol Extract and Mode of Action

Table 1

Bacteria strains and clinical isolates feature used in the study.
BacteriaCharacteristicsReferences
  
Escherichia coli  [19]
ATCC10536Reference strains
E.C 96Clinical isolate: , , , , , , ,
E.C 99Clinical isolate: , , , , , , ,
E.C 136Clinical isolate: , , , , , , ,
E.C 137Clinical isolate: , , , , , , ,
E.C 146Clinical isolate: , , , , , , ,
Enterococcus aerogenes 
ATCC 13048Reference strains
ENT 118Clinical isolate: , , , , , , ,
ENT 119Clinical isolate: , , , , , , ,
ENT 144Clinical isolate: , , , , , ,
Klebsiella pneumoniae 
ATCC 11296Reference strains
KL 111Clinical isolate: , , , , , , ,
KL 128Clinical isolate: , , , , , , ,
Salmonella enterica serovar typhi 
ATCC 6539Reference strains
SAL 9Clinical isolate: , , , , , , ,
SAL 21Clinical isolate: , , , , , , ,
Salmonella enterica serovar paratyphi AClinical isolate: , , , , , [20]
Salmonella enterica serovar paratyphi BClinical isolate: , , , , ,
Salmonella enterica serovar typhimuriumClinical isolate: , , , , ,
Pseudomonas aeruginosa  
ATCC 27853Reference strains
CIP 76110Reference strains
Providencia stuartii  [21]
PS 2636Clinical MDR isolate, AcrAB-TolC
NEA 16Clinical MDR isolate, AcrAB-TolC
Gram+  
Staphylococcus aureus  [22]
ATCC 25923Reference strains
MRSA 9Clinical multidrug isolate: , , , , , IMP/
MRSA 11Clinical multidrug isolate: , , , , IM/
MRSA 12Clinical multidrug isolate: , , , , IM/
MRSA 3Clinical multidrug isolate: , , ,
MRSA 4Clinical multidrug isolate: , , ,
ST 9Clinical isolate: , , , , [19]
ST 60Clinical isolate: , , , , ,
ST 113Clinical isolate: , , , , ,
ST 118Clinical isolate: , , , , ,
ST 120Clinical isolate: , , , , ,
ST 130Clinical isolate: , , , , ,
AN: amikacin, AM: ampicillin, AMC: amoxicillin-clavulanate, CHL: chloramphenicol, CFM: cefixime, CIP: ciprofloxacin, CRO: ceftriaxone, DO: doxycyclin, E: erythromycin, FLX: flomoxef, IMP: imipenem, IM/CS: imipenem/cilastatin sodium, K: kanamycin, NA: nalidixic acid, NOR: norfloxacin, OFX: ofloxacin, TE: tetracycline, SXT: trimethoprim-sulfamethoxazole, VA: vancomycin. R: resistant, S: sensible, and I: intermediate.